Inherited and acquired degenerative diseases of the retina are a significant cause of incurable vision loss worldwide. David Gamm, MD, PhD, utilizes stem cell technology to test ways to preserve or restore vision in people …
When Madison attorney David Walsh learned 17 years ago that his sons have a genetic disorder that causes blindness, he went into action mode.
But the specks in the Petri dishes were the result of years of research in the laboratory of David Gamm, an ophthalmologist at the UW’s Waisman Center. And as members of the Reese family carefully cradled the dishes, they held the future of their descendants’ eyesight in their hands.
For the first time, Wisconsin researchers have taken skin from patients and, using induced pluripotent stem cell (iPSC) technology, turned them into a laboratory model for an inherited type of macular degeneration.
David Gamm received the Visionary Award from the Foundation Fighting Blindness at the Dining in the Dark event.
David Gamm has been selected as director of the University of Wisconsin Eye Research Institute (ERI).
For the first time, scientists at the UW-Madison have made early retina structures containing proliferating neuroretinal progenitor cells using induced pluripotent stem (iPS) cells derived from human blood.
Soon, some treatments for blinding eye diseases might be developed and tested using retina-like tissues produced from the patient’s own skin, thanks to a series of discoveries reported by a team of University of Wisconsin-Madison …
Waisman Center researcher David M. Gamm, MD, PhD, has been awarded a vision research grant for “The Role of MITF in Early Retinal Fate Determination in Human Embryonic Stem Cells”.
A team of scientists from the School of Medicine and Public Health has successfully grown multiple types of retina cells from two types of stem cells — suggesting a future in which damaged retinas could be repaired by cells grown from the patient’s own skin.